Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.

Biotechnology

Health Care

Hospital

Pharmaceutical

Oblique Therapeutics

Oblique Therapeutics' headquarters in Göteborg, Sweden

Christer Nordstedt

Lotta Ostler

Göran Gannedahl

Olof Larsson

Hans-Peter Ostler

Pernilla Wittung-Stafshede

Rolf Karlsten

Daniel Johnsson

Marianne Dicander Alexandersson

Camilla Svensson

Stefan Ståhl

Lars Molinder

Elias Arnér

The Board and Advisory team at Oblique Therapeutics provides strategic guidance and governance oversight, leveraging their expertise to support the development of innovative antibody-based treatments for chronic pain and metastatic cancer.

Board and Advisory

The Leadership Team at Oblique Therapeutics is responsible for steering the company's strategic direction, overseeing the development of innovative antibody-based therapies, and ensuring efficient resource allocation. They collaborate across functions to align clinical, financial, and business objectives, driving initiatives that promote the advancement of chronic pain and metastatic cancer treatments. Their collective expertise fosters a culture of innovation and accountability, essential for achieving the company's mission.

Leadership Team

The Research and Development team at Oblique Therapeutics focuses on creating innovative antibody-based medications for chronic pain and metastatic cancer. Comprising experts in medicinal chemistry, clinical pain, and preclinical research, the team collaborates to advance drug candidates from early-stage research through preclinical development, ensuring the efficacy and safety of new therapeutic approaches.

Research and Development

Oblique Therapeutics

Org chart

Board & advisors

Teams

Board and Advisory

Leadership Team

Research and Development

Offices

Oblique Therapeutics

Org chart

Board & advisors

Teams

Board and Advisory

Leadership Team

Research and Development

Offices

Related companies